作者：
Andrea E,Wahner Hendrickson [1]
;
Daniel W,Visscher [2]
;
Xiaonan,Hou [1]
;
Krista M,Goergen [3]
;
Hunter J,Atkinson [3]
;
Thomas G,Beito [4]
;
Vivian,Negron [5]
;
Wilma L,Lingle [5]
;
Amy K,Bruzek [5]
;
Rachel M,Hurley [6]
;
Jill M,Wagner [1]
;
Karen S,Flatten [7]
;
Kevin L,Peterson [7]
;
Paula A,Schneider [7]
;
Melissa C,Larson [3]
;
Matthew J,Maurer [3]
;
Kimberly R,Kalli [8]
;
Ann L,Oberg [3]
;
S John,Weroha [1]
;
Scott H,Kaufmann [6]
作者单位：
Division of Medical Oncology, Mayo Clinic, Rochester, MN 55905, USA.
[1]
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA.
[2]
Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN 55905, USA.
[3]
Hybridoma Core, Mayo Clinic, Rochester, MN 55905, USA.
[4]
Pathology Research Core, Mayo Clinic, Rochester, MN 55905, USA.
[5]
Department of Molecular Pharmacology & Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905, USA.
[6]
Division of Oncology Research, Mayo Clinic, Rochester, MN 55905, USA.
[7]
Women's Cancer Program, Mayo Clinic, Rochester, MN 55905, USA.
[8]
DOI
10.3390/cancers13236043
PMID
34885153
发布时间
2022-12-13
换一批
换一批
